Invention Grant
- Patent Title: Spiro-lactam NMDA receptor modulators and uses thereof
-
Application No.: US15638669Application Date: 2017-06-30
-
Publication No.: US09932347B2Publication Date: 2018-04-03
- Inventor: M. Amin Khan
- Applicant: Aptinyx Inc.
- Applicant Address: US IL Evanston
- Assignee: Aptinyx Inc.
- Current Assignee: Aptinyx Inc.
- Current Assignee Address: US IL Evanston
- Agency: Goodwin Procter LLP
- Main IPC: C07D487/10
- IPC: C07D487/10 ; A61K31/4025 ; A61K38/00 ; C07D471/20 ; C07K16/00
Abstract:
Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity. Such compounds can be used in the treatment of conditions such as depression and related disorders. Orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
Public/Granted literature
- US20170334922A1 SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF Public/Granted day:2017-11-23
Information query
